Index of medicine substances

Artemether + lumefantrine  •  Antiparasitic products, insecticides and repellents | Antimalarials | Artemisinin and derivatives, combinations (P01BF01)

Artesunate  •  Antiparasitic products, insecticides and repellents | Antimalarials | Artemisinin and derivatives, plain (P01BE03)

Articaine + adrenaline  •  Nervous system | Anesthetics | Anesthetics, local | Amides (N01BB58)

Asciminib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | BCR-ABL tyrosine kinase inhibitors (L01EA06)

Ascorbic acid  •  Alimentary tract and metabolism | Ascorbic acid (vitamin C), incl. combinations | Ascorbic acid (vitamin C), plain (A11GA01)

Ascorbic acid + tocopherol + beta-carotene + selenium  •  Alimentary tract and metabolism | Other vitamin products, combinations | Vitamins with minerals (A11JBN1)

Asenapine  •  Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines (N05AH05)

Asfotase alfa  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes (A16AB13)

Asparaginase  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents (L01XX02)

Aspartic acid + pyridoxine  •  Alimentary tract and metabolism | Liver therapy, lipotropics (A05BAN3)

Ataluren  •  Musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system (M09AX03)

Atazanavir  •  Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors (J05AE08)

Atazanavir + cobicistat  •  Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections, combinations (J05AR15)

Atenolol  •  Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective (C07AB03)

Atezolizumab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors (L01FF05)

Atogepant  •  Nervous system | Antimigraine preparations | Calcitonin gene-related peptide (CGRP) antagonists (N02CD07)

Atomoxetine  •  Nervous system | Psychostimulants, agents used for adhd and nootropics | Centrally acting sympathomimetics (N06BA09)

Atorvastatin  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Hmg coa reductase inhibitors (C10AA05)

Atorvastatin + amlodipine  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs (C10BX03)

Atorvastatin + ezetimibe  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Combinations of various lipid modifying agents (C10BA05)

Atorvastatin + perindopril  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs (C10BX15)

Atorvastatin + perindopril + amlodipine  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Lipid modifying agents in combination with other drugs (C10BX11)

Atosiban  •  Genito urinary system and sex hormones | Other gynecologicals | Other gynecologicals (G02CX01)

Atovaquone + proguanil  •  Antiparasitic products, insecticides and repellents | Antimalarials | Biguanides (P01BB51)

Atracurium  •  Musculo-skeletal system | Muscle relaxants | Muscle relaxants, peripherally acting agents | Other quaternary ammonium compounds (M03AC04)

Atropine  •  Alimentary tract and metabolism | Belladonna and derivatives, plain | Belladonna alkaloids, tertiary amines (A03BA01)

Atropine sulfate + ergoton + propranolol + amobarbital sodium  •  Cardiovascular system | (C07NAN1)

Autologous human cartilaginous cells  •  Musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system (M09AX02)

Avacopan  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Complement inhibitors (L04AJ05)

Avalglucosidase alfa  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes (A16AB22)